Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion: 2010-2024

Historic Depreciation and Depletion for Rockwell Medical (RMTI) over the last 15 years, with Dec 2024 value amounting to $1.6 million.

  • Rockwell Medical's Depreciation and Depletion changed negligibly% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.6 million for FY2024, which is 33.33% up from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Depreciation and Depletion is $1.6 million, which was up 33.33% from $1.2 million recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Depreciation and Depletion registered a high of $1.6 million during FY2024, and its lowest value of $600,000 during FY2022.
  • Moreover, its 3-year median value for Depreciation and Depletion was $1.2 million (2023), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Rockwell Medical's Depreciation and Depletion dropped by 19.90% in 2021, and later skyrocketed by 100.00% in 2023.
  • Over the past 5 years, Rockwell Medical's Depreciation and Depletion (Yearly) stood at $834,000 in 2020, then decreased by 19.90% to $668,000 in 2021, then fell by 10.18% to $600,000 in 2022, then spiked by 100.00% to $1.2 million in 2023, then skyrocketed by 33.33% to $1.6 million in 2024.